A 2026 UK evidence review of postural orthostatic tachycardia syndrome cognitive dysfunction, cerebral blood flow, the 2025 Adelaide SPECT study, the 14-fold Read the full review Tick-Borne Disease & Neuroinflammation 3 June 2026 Dihexa for Lyme Disease Brain Fog, Neuroborreliosis & PTLDS: The 2026 UK Review Can Dihexa help Lyme disease brain fog or Post-Treatment Lyme Disease Syndrome (PTLDS)
Tirzepatide: A Scientific Lens From a scientific standpoint, the difference lies in their receptor targets: Semaglutide activates GLP-1 receptors
Gastrointestinal side effects are common across incretin-based therapies: nausea, vomiting, diarrhea, constipation and bloating
Our findings were robust to the imputation methodology utilized to address this, and we did not find evidence that missingness was associated with any particular patient type or profile, but to the extent that there may be a pattern to the missingness in the availability of covariates or outcomes data, this may impact the magnitude of our findings
:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)
